Pharmacy & Consumer Wellness: Front Store Optimization
Targeting $21.5B in front store revenue with smarter coupons, better inventory, and margin protection across 8,979 stores.
Synthetic Data Assets
Pre-aggregated from 10B transactions
| Customers | 10,000,000 |
| Transactions (2yr) | 10,000,000,000 |
| Products (OTC + Rx) | 12,000 |
| Store Locations | 8,983 |
| Coupon Clip Events | 16,400,000 |
| Transaction Date Range | 2024-01 to 2025-12 |
Product Tier Strategy
How we bucket products based on coupon behavior
Curious: Clip but don't redeem → sweeten the offer slightly
Organic Stars: Sell well without coupons → stop discounting, protect margin
Hidden Gems: High margin, low velocity → promote to increase discovery
Front Store Revenue Trend (10-K)
Annual front store revenue with same-store-sales growth rate
Top Products by Revenue
Ranked from 10B synthetic transactions. Each tier gets a different coupon playbook based on how customers actually engage with discounts.
Revenue by Category
OTC categories ranked by synthetic transaction revenue
Sample Product Tiles
Sample products by tier — each one gets a different coupon approach
SmartRewards & Digital Coupons
16.4M coupon clip events across 10M customers. We're building on top of one of the largest retail loyalty programs in the country.
Redemption by Discount Type
Dollar-off converts best; BOGO underperforms despite perceived value
Coupon Strategy Opportunities
Tailored moves for each customer-product pair
Markets & Store Performance
8,983 synthetic stores mapped to real store IDs, weighted by actual store density. Revenue per store tells us where to deploy first.
Top Markets by Revenue (Synthetic)
State-level rollup from customer purchase data
Store Count Trend (10-K)
Net closures of ~250-300 stores per year
| Year | Start | Opened | Closed | End | Net Change |
|---|---|---|---|---|---|
| FY2023 | 9,674 | 39 | (318) | 9,395 | -279 |
| FY2024 | 9,395 | 39 | (299) | 9,135 | -260 |
| FY2025 | 9,135 | 87 | (243) | 8,979 | -156 |
10-K Financial Reality
Straight from the SEC 10-K filings — FY2024 (filed Feb 12, 2025) and FY2025 (filed Feb 10, 2026). Every projection ties back to these.
Consolidated Revenue ($M)
Source: 10-K SEC filings
| Line Item | FY2023 | FY2024 | FY2025 | FY24 vs 23 | FY25 vs 24 |
|---|---|---|---|---|---|
| Products | $245,138 | $231,521 | $249,908 | -5.6% | +7.9% |
| Premiums | $99,192 | $122,896 | $134,751 | +23.9% | +9.6% |
| Services | $12,293 | $16,239 | $15,175 | +32.1% | -6.6% |
| Net Investment Income | $1,153 | $2,153 | $2,233 | +86.7% | +3.7% |
| TOTAL REVENUES | $357,776 | $372,809 | $402,067 | +4.2% | +7.8% |
Segment Revenue ($M)
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Health Care Benefits | $105,646 | $130,665 | $143,354 |
| Health Services (PBM) | $186,843 | $173,605 | $190,425 |
| Pharmacy & Consumer Wellness | $116,763 | $124,500 | $139,367 |
| ↳ Pharmacy | $92,111 | $100,687 | $115,510 |
| ↳ Front Store | $22,458 | $21,522 | $21,459 |
| ↳ Front Store % of P&CW | 21.1% | 19.1% | 17.1% |
P&CW Margins & Profitability ($M)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cost of Products Sold | $91,447 | $99,337 | $113,583 |
| Gross Profit | $25,316 | $25,163 | $25,784 |
| Gross Margin | 21.7% | 20.2% | 18.5% |
| Adjusted Operating Income | $5,963 | $5,774 | $6,040 |
| Adj. OI Margin | 5.1% | 4.6% | 4.3% |
Earnings & Same-Store Sales
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Net Income | $8,344M | $4,614M | $1,768M |
| Diluted EPS | $6.47 | $3.66 | $1.39 |
| Pharmacy SSS | +13.6% | +12.3% | +18.0% |
| Front Store SSS | +0.3% | -2.1% | +1.2% |
| Rx Volume Growth | +3.9% | +6.8% | +8.0% |
| Prescriptions Filled (M) | 1,649.1 | 1,715.5 | 1,808.8 |
Revenue Impact: Conservative Projections
Anchored to real 10-K numbers. We're intentionally conservative — better to beat the number than miss it.
Why Conservative Wins
The market already priced in the decline ($6.47 → $3.66 → $1.39 EPS). If we go conservative and beat it:
- Stock re-rates on the earnings surprise
- Management builds credibility
- The rec system gets more funding
If we swing big and miss: credibility tanks, program gets killed.
With EPS falling, margins compressing, and stores closing, anything above "moderate" won't fly with investors or the board.
What Happens If We Do Nothing
- Coupon waste continues: 65% of clips go unredeemed
- Hidden gems stay hidden: High-margin products nobody finds
- Organic stars get discounted: Blanket promos eat margin on products that sell fine without them
- No personalization: Every customer sees the same offers
- Competitive gap widens: Other retailers with rec systems keep pulling ahead
Shrinkage & Loss Prevention
No shrinkage figures in the 10-K. Estimates below come from Congressional testimony, NRF industry data, and analyst extrapolation. This is a defensive play — protecting what we already have.
Loss Prevention Device ROI
Estimated costs and deterrence rates (industry averages)
| Device | Annual Cost | Target Shrink | Est. Savings | Net Savings | ROI |
|---|---|---|---|---|---|
| EAS Tags (disposable) | $0.4M | 30% | $61.8M | $61.4M | +14,750% |
| RFID Inventory Tracking | $1.0M | 20% | $58.3M | $57.3M | +5,630% |
| Locked Display Cases | $15.8M | 15% | $43.8M | $28.0M | +177% |
| Self-Checkout AI | $137.0M | 10% | $29.2M | ($107.8M) | -79% |
| TOTAL | $154.2M | — | $193.1M | $38.9M | +25% |
Combined Revenue Opportunity
Rec system + loss prevention combined
| Recommendation system (conservative) | $200-430M |
| Loss prevention (EAS + RFID only) | $118.7M |
| Combined Conservative Estimate | $319-549M |